that made sales of £1.3 billion in the first nine months of 2024 and is one of the company's top products. It is one of five key product launches that GSK is hoping to make this year along with ...
Shares of GlaxoSmithKline Pharmaceuticals Ltd ended at ₹2,608, up by ₹275.75, or 11.82%, on the BSE. Brokerage firms, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback